Hudson Bay Capital Management
ANIP icon

Hudson Bay Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Hudson Bay Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,000
Closed -$434K – 207
2015
Q2 		$434K Buy
+7,000
New +$417K 0.01% 207
2015
Q1 		– Sell
-35,184
Closed -$1.98M – 177
2014
Q4 		$1.98M Buy
+35,184
New +$1.55M 0.05% 131

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hudson Bay Capital Management's ANIP Position: Q3 2015 in Review

Hudson Bay Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2015, closing a stake of 7,000 shares — an estimated $434K sold.

Hudson Bay Capital Management first reported a position in ANIP in Q4 2014 and held it in 2 quarters. The position peaked at $1.98M in Q4 2014. 121 funds tracked by Wall St. Rank hold ANIP as of Q3 2015.

  • Hudson Bay Capital Management reported no remaining ANI Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Hudson Bay Capital Management sold 7,000 ANI Pharmaceuticals shares in Q3 2015, an estimated $434K.
  • Hudson Bay Capital Management first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Hudson Bay Capital Management's ANI Pharmaceuticals position peaked at $1.98M in Q4 2014.
  • 121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2015.

Based on Hudson Bay Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.